Trial Profile
Effects of insulin detemir versus insulin aspart on oxidative stress in patients with type 2 diabetes mellitus and poor glycaemic control
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2011
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 04 Jul 2011 New trial record
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.